The Ewing's sarcoma fusion protein, EWS-FLI, binds Runx2 and blocks osteoblast differentiation

Xiaodong Li, Meghan Elizabeth McGee Lawrence, Matthew Decker, Jennifer J. Westendorf

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Ewing's sarcomas are highly aggressive round cell tumors of bone and soft tissues that afflict children and young adults. The majority of these tumors harbor the t(11;22) translocation and express the fusion protein EWS-FLI. Modern molecular profiling experiments indicate that Ewing's tumors originate from mesenchymal precursors in young individuals. EWS-FLI alters the morphology of mesenchymal cells and prevents lineage specification; however, the molecular mechanisms for differentiation arrest are unclear. We recently showed that EWS-FLI binds Runx2, a master regulator of osteoblast differentiation. In this report, we demonstrate that FLI sequences within EWS-FLI are responsible for interactions with Runx2. EWS-FLI blocks the expression of osteoblastic genes in a multipotent progenitor cell line that requires Runx2 to integrate bone morphogenic protein (Bmp)2 signaling while increasing proliferation and altering cell morphology. These results demonstrate that EWS-FLI blocks the ability of Runx2 to induce osteoblast specification of a mesenchymal progenitor cell. Disrupting interactions between Runx2 and EWS-FLI1 may promote differentiation of the tumor cell.

Original languageEnglish (US)
Pages (from-to)933-943
Number of pages11
JournalJournal of cellular biochemistry
Volume111
Issue number4
DOIs
StatePublished - Nov 1 2010
Externally publishedYes

Fingerprint

Ewing's Sarcoma
Osteoblasts
Tumors
Bone and Bones
Neoplasms
Bone
Cells
Cell Lineage
Specifications
Mesenchymal Stromal Cells
Cell Differentiation
Young Adult
Stem Cells
Ports and harbors
Cell Proliferation
Gene Expression
Cell Line
Genes
Tissue
EWS-FLI fusion protein

Keywords

  • AML-3
  • Bmp2
  • Cbfa1
  • EWSR1
  • Ets
  • FLI1
  • PEBP2aA

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

The Ewing's sarcoma fusion protein, EWS-FLI, binds Runx2 and blocks osteoblast differentiation. / Li, Xiaodong; McGee Lawrence, Meghan Elizabeth; Decker, Matthew; Westendorf, Jennifer J.

In: Journal of cellular biochemistry, Vol. 111, No. 4, 01.11.2010, p. 933-943.

Research output: Contribution to journalArticle

@article{07fb210040fc47d29eaab0b30208a4ac,
title = "The Ewing's sarcoma fusion protein, EWS-FLI, binds Runx2 and blocks osteoblast differentiation",
abstract = "Ewing's sarcomas are highly aggressive round cell tumors of bone and soft tissues that afflict children and young adults. The majority of these tumors harbor the t(11;22) translocation and express the fusion protein EWS-FLI. Modern molecular profiling experiments indicate that Ewing's tumors originate from mesenchymal precursors in young individuals. EWS-FLI alters the morphology of mesenchymal cells and prevents lineage specification; however, the molecular mechanisms for differentiation arrest are unclear. We recently showed that EWS-FLI binds Runx2, a master regulator of osteoblast differentiation. In this report, we demonstrate that FLI sequences within EWS-FLI are responsible for interactions with Runx2. EWS-FLI blocks the expression of osteoblastic genes in a multipotent progenitor cell line that requires Runx2 to integrate bone morphogenic protein (Bmp)2 signaling while increasing proliferation and altering cell morphology. These results demonstrate that EWS-FLI blocks the ability of Runx2 to induce osteoblast specification of a mesenchymal progenitor cell. Disrupting interactions between Runx2 and EWS-FLI1 may promote differentiation of the tumor cell.",
keywords = "AML-3, Bmp2, Cbfa1, EWSR1, Ets, FLI1, PEBP2aA",
author = "Xiaodong Li and {McGee Lawrence}, {Meghan Elizabeth} and Matthew Decker and Westendorf, {Jennifer J.}",
year = "2010",
month = "11",
day = "1",
doi = "10.1002/jcb.22782",
language = "English (US)",
volume = "111",
pages = "933--943",
journal = "Journal of Cellular Biochemistry",
issn = "0730-2312",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - The Ewing's sarcoma fusion protein, EWS-FLI, binds Runx2 and blocks osteoblast differentiation

AU - Li, Xiaodong

AU - McGee Lawrence, Meghan Elizabeth

AU - Decker, Matthew

AU - Westendorf, Jennifer J.

PY - 2010/11/1

Y1 - 2010/11/1

N2 - Ewing's sarcomas are highly aggressive round cell tumors of bone and soft tissues that afflict children and young adults. The majority of these tumors harbor the t(11;22) translocation and express the fusion protein EWS-FLI. Modern molecular profiling experiments indicate that Ewing's tumors originate from mesenchymal precursors in young individuals. EWS-FLI alters the morphology of mesenchymal cells and prevents lineage specification; however, the molecular mechanisms for differentiation arrest are unclear. We recently showed that EWS-FLI binds Runx2, a master regulator of osteoblast differentiation. In this report, we demonstrate that FLI sequences within EWS-FLI are responsible for interactions with Runx2. EWS-FLI blocks the expression of osteoblastic genes in a multipotent progenitor cell line that requires Runx2 to integrate bone morphogenic protein (Bmp)2 signaling while increasing proliferation and altering cell morphology. These results demonstrate that EWS-FLI blocks the ability of Runx2 to induce osteoblast specification of a mesenchymal progenitor cell. Disrupting interactions between Runx2 and EWS-FLI1 may promote differentiation of the tumor cell.

AB - Ewing's sarcomas are highly aggressive round cell tumors of bone and soft tissues that afflict children and young adults. The majority of these tumors harbor the t(11;22) translocation and express the fusion protein EWS-FLI. Modern molecular profiling experiments indicate that Ewing's tumors originate from mesenchymal precursors in young individuals. EWS-FLI alters the morphology of mesenchymal cells and prevents lineage specification; however, the molecular mechanisms for differentiation arrest are unclear. We recently showed that EWS-FLI binds Runx2, a master regulator of osteoblast differentiation. In this report, we demonstrate that FLI sequences within EWS-FLI are responsible for interactions with Runx2. EWS-FLI blocks the expression of osteoblastic genes in a multipotent progenitor cell line that requires Runx2 to integrate bone morphogenic protein (Bmp)2 signaling while increasing proliferation and altering cell morphology. These results demonstrate that EWS-FLI blocks the ability of Runx2 to induce osteoblast specification of a mesenchymal progenitor cell. Disrupting interactions between Runx2 and EWS-FLI1 may promote differentiation of the tumor cell.

KW - AML-3

KW - Bmp2

KW - Cbfa1

KW - EWSR1

KW - Ets

KW - FLI1

KW - PEBP2aA

UR - http://www.scopus.com/inward/record.url?scp=78049248010&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78049248010&partnerID=8YFLogxK

U2 - 10.1002/jcb.22782

DO - 10.1002/jcb.22782

M3 - Article

C2 - 20665663

AN - SCOPUS:78049248010

VL - 111

SP - 933

EP - 943

JO - Journal of Cellular Biochemistry

JF - Journal of Cellular Biochemistry

SN - 0730-2312

IS - 4

ER -